SCHEMBL7141353

SCHEMBL7141353

Cc1[nH]c2ccc(NS(=O)(=O)C(C)C)cc2c1CCN(C)Cc1cccc2ncncc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1F P30939 1/20 0.36
KMT2A Q03164 4/20 0.34
NPSR1 Q6W5P4 3/20 0.34
ALDH1A1 P00352 3/20 0.34
MAPT P10636 8/20 0.34
LMNA P02545 4/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
NTRK1 P04629 4/20 0.33
MEN1 O00255 2/20 0.33
HTR7 P34969 2/20 0.33
HTR6 P50406 2/20 0.33
GAA P10253 1/20 0.33
ADRA2A P08913 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
HTR2B P41595 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2B Q13224 1/20 0.33
ATM Q13315 1/20 0.33
HTR1A P08908 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8549939 0.85 ALDH1A1 (0.33) KMT2AALDH1A1MAPTLMNASMN1; SMN2
SCHEMBL8554008 0.84 BRAF (0.30)
SCHEMBL8181305 0.79 EGFR (0.41) HTR1FKMT2ANPSR1ALDH1A1MAPT
SCHEMBL7147572 0.75 MAPT (0.43) KMT2ANPSR1ALDH1A1MAPTLMNA
SCHEMBL7146842 0.73 BRD4 (0.47) MAPTSMN1; SMN2HTR7HTR6GAA
SCHEMBL8180841 0.68 HTR1F (0.44) HTR1FKMT2ANPSR1ALDH1A1MAPT
SCHEMBL8931396 0.67 BRD4 (0.48) MAPTSMN1; SMN2HTR7HTR6GAA
SCHEMBL8192418 0.66 HSP90AA1 (0.38) KMT2AALDH1A1MAPTLMNASMN1; SMN2
Acetic Acid SCHEMBL7142201 0.66 BRD4 (0.43) HTR1FKMT2ANPSR1ALDH1A1MAPT
SCHEMBL8550531 0.66 EGFR (0.42) NPSR1ALDH1A1MAPTLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0768301-B1 N-(2-substituted-3-(2-aminoethyl)-1H-indol-5-yl)-amides as new 5-HT1F agonists LILLY CO ELI (US) 2003-04-02 EP disclosed
US-6126932-A INSOLUBLE POLYMER BEARING PENDANT SIDE CHAINS, SAID SIDE CHAINS EACH TERMINATING WITH THE 1-(3-(1-PYRROLIDINYL)-PROPYL)-3-ETHYLCARBODIIMIDE MOIETY. ELI LILLY AND COMPANY (US) 2000-10-03 US disclosed
EP-0994109-A2 1-(3-(1-Pyrrolidinyl)propyl)-3-ethylcarbodiimide and a solid phase coupling agent ELI LILLY AND COMPANY (US) 2000-04-19 EP disclosed
US-5998630-A A 1-(3-(1-PYRROLIDINYL)PROPY)-3-ETHYLCARBODIIMIDE ELI LILLY AND COMPANY (US) 1999-12-07 US disclosed
WO-1997013512-A1 N-[2-SUBSTITUTED-3-(2-AMINOETHYL)-1H-INDOL-5-YL]-AMIDES: NEW 5-HT1F AGONISTS ELI LILLY AND COMPANY (US) 1997-04-17 WO disclosed
EP-0768301-A1 N-(2-substituted-3-(2-aminoethyl)-1H-indol-5-yl)-amides as new 5-HT1F agonists ELI LILLY AND COMPANY (US) 1997-04-16 EP disclosed